Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Non-Current Deffered Revenue (2017 - 2021)

Historic Non-Current Deffered Revenue for Solid Biosciences (SLDB) over the last 3 years, with Q3 2021 value amounting to $2.3 million.

  • Solid Biosciences' Non-Current Deffered Revenue changed N/A to $2.3 million in Q3 2021 from the same period last year, while for Sep 2021 it was $2.3 million, marking a year-over-year change of. This contributed to the annual value of $10.4 million for FY2020, which is N/A changed from last year.
  • Per Solid Biosciences' latest filing, its Non-Current Deffered Revenue stood at $2.3 million for Q3 2021.
  • In the past 5 years, Solid Biosciences' Non-Current Deffered Revenue ranged from a high of $10.4 million in Q4 2020 and a low of $2.3 million during Q3 2021
  • Its 3-year average for Non-Current Deffered Revenue is $5.4 million, with a median of $4.3 million in 2021.